Waldo Ullah | Biochemical Pharmacology | Best Researcher Award

Posted on by chemical Scientist

Prof. Dr. Waldo Ullah | Biochemical Pharmacology | Best Researcher Award

Assistant professor at Pontifical Catholic University of Valparaíso, Chile.

🔬 Short Biography 🌿💊📚

Dr. Waldo Acevedo Castillo 🧑‍🔬 is an Associate Professor at the Institute of Chemistry, Faculty of Science, Pontificia Universidad Católica de Valparaíso 🇨🇱. With a Ph.D. and M.Sc. in Engineering Sciences from Pontificia Universidad Católica de Chile 🎓, Dr. Acevedo has established himself as a pioneer in food chemistry and structural bioinformatics 🧪. His research focuses on the molecular characterization of organoleptic food additives 🍬 and rational drug design 💊. He has published extensively in high-impact journals and contributed to multiple interdisciplinary projects in biochemistry and pharmacology. Passionate about teaching and mentoring 👨‍🏫, he guides undergraduate and graduate students in bioinformatics and biochemical research. Dr. Acevedo also plays an active role in academic peer review, editorial boards, and science outreach 🌍. His career blends deep scientific inquiry with educational innovation and societal engagement, making him a dynamic force in the global chemistry community 🌐.

PROFILE 

SCOPUS 

ORCID 

🔍 Summary of Suitability:

Dr. Waldo Acevedo Castillo exemplifies the qualities of an outstanding researcher, with a strong foundation in computational bioinformatics, food chemistry, and biochemical pharmacology. As an Associate Professor at Pontificia Universidad Católica de Valparaíso, he has consistently demonstrated academic excellence, interdisciplinary innovation, and impactful research. His academic background, scientific publications, mentorship, and leadership roles underscore a career devoted to advancing molecular science and contributing to global health and nutrition challenges.

📘 Education & Experience

  • 🎓 Ph.D. in Engineering Sciences, Pontificia Universidad Católica de Chile (2017)

  • 🎓 M.Sc. in Engineering, Pontificia Universidad Católica de Chile (2016)

  • 📚 Diploma in University Teaching, PUCV (2019)

  • 📚 Diploma in Virtual University Training, PUCV (2020)

  • 💻 Graduate in Bioinformatics, Universidad de Talca (2009)

  • 👨‍🏫 Associate Professor, Institute of Chemistry, PUCV

  • 🧬 Bioinformatics Engineer, Universidad de Talca (2009)

  • 📖 Scientific Reviewer, multiple journals including Food Chemistry and Scientific Reports

  • 🔬 Editorial Board Member, Pharmaceutics and Drug Innovation, Journal of Drug Design and Research

Professional Development 🚀📖

Dr. Waldo Acevedo continuously enhances his professional skills through diverse academic and research activities 📈. He has completed numerous training programs in virtual education, AI in teaching, curriculum development, and project formulation at PUCV 🎓. His involvement in interdisciplinary projects spans vertical farming 🌿, enzymatic hydrolysis, and drug formulation for dermatological conditions 🧴. As a mentor, he has supervised numerous undergraduate and postgraduate theses 🧑‍🎓. Dr. Acevedo actively contributes to international research communities as a reviewer and editorial board member 📰. He is also a dedicated science communicator, promoting STEM outreach through the Explora Academies of Research and School Innovation 🧠. His collaborative spirit has led to roles in national research grants and innovation-driven projects 💡. His work bridges cutting-edge science, education, and public engagement, positioning him as a multifaceted professional in molecular chemistry, bioinformatics, and pharmacological sciences 🌍.

Research Focus 🔍🤖

Dr. Waldo Acevedo’s research centers around Food Chemistry, Biochemical Pharmacology, and Structural Bioinformatics 🔍. He investigates the molecular interactions of food additives, especially sweeteners, with human taste receptors 🍭. His research applies computational tools like molecular docking and dynamics to understand taste perception and improve food quality. Additionally, Dr. Acevedo explores the rational design of anticancer and antimicrobial agents 🧬, targeting enzymes and proteins like SIRT2, EGFR, COX-2, and bitter taste receptors. He has participated in drug discovery efforts and virtual screening campaigns that integrate in silico and in vitro approaches 💊. His interdisciplinary projects have included work on skin microbiome modulation, environmental toxicology, and salmon immunology 🐟. With a strong computational background, he brings innovation to molecular modeling, offering insights into bioactive compound mechanisms and receptor-ligand interactions 🔬. His research contributes significantly to both health and food sciences 🌿.

Awards and Honors 🏆🎖️

  • 🧑‍⚖️ Peer Evaluator, CNA-Chile Postgraduate Area (2024–Present)

  • 🧠 Advisory Committee Member, Explora Academies of Research and School Innovation (2024–Present)

  • 🧬 Review Editor, Frontiers in Genome Editing (2024–Present)

  • 📝 Editorial Board Member, Pharmaceutics and Drug Innovation & Journal of Drug Design and Research (2023–Present)

  • 🌐 Chief of Outreach, Institute of Chemistry, PUCV (2023–Present)

  • 🧪 Member, Society of Biochemistry and Molecular Biology of Chile (SBBMCh) (2022–Present)

  • 📚 Board Collaborator, Doctorate Program in Chemistry, PUCV (2018–Present)

  • 🏆 Best Graduate Award, Universidad de Talca (2009)

  • 🌟 Stimulus to Effort Award, Gabriel & Mary Mustakis Foundation (1999)

  • 🗣️ CONICYT Doctoral Scholarship, Chile (2013–2016)

  • 🇬🇧 CORFO English Scholarship, for Global Services Industry (2010)

Publications & Citations 📚

  • Golcienė, B., Kavaliauskas, P., Acevedo, W., et al. (2025).
    Identification of 3-[(4-Acetylphenyl)(4-Phenylthiazol-2-Yl)Amino]Propanoic Acid Derivatives as Promising Anticancer Candidates Targeting SIRT2 and EGFR.
    Pharmaceuticals, 18(5). https://doi.org/10.3390/ph18050733

  • Kavaliauskas, P., Acevedo, W., et al. (2025).
    3,3′-((3-Hydroxyphenyl)azanediyl)dipropionic Acid Derivatives Against Drug-Resistant Pathogens and Cancer.
    Pathogens, 14(5), 484. https://doi.org/10.3390/pathogens14050484

  • Maldonado, J., Oliva, A., Guzmán, L., Molinari, A., Acevedo, W. (2024).
    Synthesis and Anticancer Activity of Hydroquinone-Chalcone-Pyrazoline Hybrids.
    International Journal of Molecular Sciences, 25, 7281. https://doi.org/10.3390/ijms25137281

  • Kavaliauskas, P., Acevedo, W., et al. (2024).
    Bis(thiazol-5-yl)phenylmethane Derivatives Against MDR Staphylococcus aureus.
    PLOS ONE, 19(3), e0300380. https://doi.org/10.1371/journal.pone.0300380

  • Maldonado, J., Oliva, A., Molinari, A., Acevedo, W. (2023).
    Naphthohydroquinone-Derived Chalcones as Anticancer Agents.
    Molecules, 28, 7172. https://doi.org/10.3390/molecules28207172

  • Acevedo, W., Morán-Figueroa, R., Vargas-Chacoff, L., Morera, F. J., Pontigo, J. P. (2023).
    NLRP3 Inflammasome in Salmo salar: Structural and Transcriptomic Insights.
    International Journal of Molecular Sciences, 24, 14556. https://doi.org/10.3390/ijms241914556

  • Maldonado, J., Acevedo, W., et al. (2022).
    Naphthoisoxazolequinone Carboxamides as Antitumor Agents.
    Polycyclic Aromatic Compounds, 42(4), 1–24. https://doi.org/10.1080/10406638.2022.2095410

  • Kavaliauskas, P., Acevedo, W., et al. (2022).
    Naphthoquinone Derivatives Targeting COX-2.
    Pharmaceuticals, 15, 541. https://doi.org/10.3390/ph15050541

  • Balada, C., Castro, M., Fassio, C., Zamora, A., Marchant, M. J., Acevedo, W., Guzmán, L. (2021).
    Genetic Diversity of Curcuma longa from Rapa Nui.
    Saudi Journal of Biological Sciences, 28, 707–716. https://doi.org/10.1016/j.sjbs.2020.10.062

  • Acevedo, W., Cañón, P., Gómez, F., Huerta, J., Aguayo, D., Agosin, E. (2020).
    L-Malate Protonation and Malolactic Enzyme Activity in Oenococcus oeni.
    Molecules, 25(15), 3431–3447. https://doi.org/10.3390/molecules25153431

🔍 Conclusion:

Dr. Waldo Acevedo Castillo stands out as a multidisciplinary researcher whose work bridges computational biology, food sciences, and pharmacology. His contributions have real-world relevance—from drug development to food safety—and his dedication to mentoring and collaborative science magnifies his impact. These attributes align perfectly with the ethos of the Best Researcher Award, making him a strong and deserving candidate for this prestigious recognition.

 

 

Shuanglin Qin | Chemical Biology | Best Researcher Award

Posted on by chemical Scientist

Prof. Shuanglin Qin | Chemical Biology | Best Researcher Award

Professor at Hunan University of Chinese Medicine , China.

Professor Shuanglin Qin 👨‍🔬, born on October 1, 1989 🎂, is a prominent researcher at the Research Center for Precision Medication of Chinese Medicine, Hunan University of Chinese Medicine 🏫. With a Ph.D. in Chemical Biology 🎓, his research focuses on anti-cancer drug discovery and traditional Chinese medicinal compounds 💊🌿. Known for his excellence in natural product-based drug development, he has earned notable accolades such as the Hunan Distinguished Young Scholars award 🏅. Prof. Qin also serves as an editorial member for prestigious journals 📚 and actively contributes to advancing chemical biology and precision medicine 🔬✨.

PROFILE 

ORCID 

SCOPUS 

🔍 Summary of Suitability:

Professor Shuanglin Qin demonstrates exceptional research caliber, leadership, and consistent scholarly impact in the fields of chemical biology and anti-cancer drug discovery. His academic journey reflects steady growth from student to professor, with groundbreaking work in natural product-based therapeutics rooted in Traditional Chinese Medicine 🌿. He has earned competitive national and provincial funding, secured editorial roles in top-tier journals, and actively contributed to the peer-review ecosystem of global scientific publications 🌍📚. These achievements mark him as a leader in his field and an ideal candidate for the Best Researcher Award.

🎓 Education & 🧪 Experience 

🎓 Education:

  • 📍 2016–2019: Ph.D., School of Pharmaceutical Science and Technology, Tianjin University

  • 📍 2013–2016: Master’s, School of Pharmacy, Jiangxi Science & Technology Normal University

  • 📍 2009–2013: Bachelor’s, School of Pharmacy, Hunan University of Chinese Medicine

🧪 Experience:

  • 🧑‍🏫 2024–2025: Professor, Hunan University of Chinese Medicine

  • 🧑‍🏫 2019–2024: Associate Professor, Hubei University of Science and Technology

Professional Development 🚀📖

Professor Shuanglin Qin is committed to continual professional advancement 🌟. As a principal investigator, he has led numerous high-impact projects under national and provincial funding programs, including the National Natural Science Foundation of China 💼🔬. He actively collaborates across disciplines to explore mechanisms of natural product-derived drugs. His editorial contributions span journals like the Journal of Oncology and Traditional Medicine Research 📝📊. As a peer reviewer for renowned scientific outlets, he ensures the integrity of research dissemination 🔍. His work fosters innovation in traditional Chinese medicine and strengthens links between academia and healthcare industries globally 🌍🧠.

Research Focus 🔍🤖

Professor Qin’s research primarily focuses on chemical biology and anti-cancer drug discovery 🧪🧬. He explores the molecular mechanisms of action and therapeutic potentials of natural products derived from traditional Chinese medicine 🌿💊. His interdisciplinary approach combines pharmacology, biochemistry, and medicinal chemistry to identify novel bioactive compounds targeting tumors 🎯. His efforts are directed toward developing precision medications with high efficacy and minimal side effects 🧠⚕️. By bridging modern technology with ancient remedies, his research significantly advances cancer therapeutics and natural product innovation 🔄🌱. His lab continues to pave the way in translational cancer research and drug development 🚀.

Awards and Honors 🏆🎖️

  • 🥇 Winner, Hunan Science Fund for Distinguished Young Scholars

  • 🏅 Winner, ChuTian Scholars Program, Hubei Province

  • 📊 Principal Investigator, National Natural Science Foundation of China projects

  • 🧪 Recipient, China Postdoctoral Science Foundation funding

  • 📘 Recognized in Youth Talent Programs by Hubei Health Commission & Education Department

  • 📝 Editorial roles in Journal of Oncology, Traditional Medicine Research, Life Research, and Medical Data Mining

  • 🔍 Reviewer for journals like European Journal of Medicinal Chemistry and Frontiers in Cell and Developmental Biology

Publications & Citations 📚

  • 📊 “Integrated evidence chain-based effectiveness evaluation of traditional Chinese medicines (Eff-iEC): A demonstration study” – Ye Luo et al., Acta Pharmaceutica Sinica B, 2025 | 📅 2025 | 📑 Cited by: 1

  • 🧬 “PROTACs coupled with oligonucleotides to tackle the undruggable” – Guangshuai Zhang et al., Journal not specified, 2025 | 📅 2025 | 📑 Cited by: 0

  • 🌿 “Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation” – Xingyun Liu et al., BMC Complementary Medicine and Therapies, 2024 | 📅 2024 | 📑 Cited by: 2

  • 🔬 “PROTAC technology: From drug development to probe technology for target deconvolution” – Si Yan et al., Journal not specified, 2025 | 📅 2025 | 📑 Cited by: 19

🔍 Conclusion:

Professor Qin’s dedication to translational cancer research, deep-rooted knowledge in natural product chemistry, and outstanding scientific contributions make him a model researcher in his domain. His influence spans innovation, education, and publication, fulfilling the highest standards for a Best Researcher Award recipient. He exemplifies not just academic productivity, but also real-world impact in advancing healthcare through traditional knowledge and modern science fusion.